MORISHITA JINTAN CO., LTD.

4524・Standard Market・Pharmaceuticals

Official website

MORISHITA JINTAN CO., LTD.

4524・Standard Market・Pharmaceuticals

Official website

MORISHITA JINTAN CO., LTD.4524

Reference Indicators

Market Cap

91¥100M

P/E (Forecast)

—

P/B

0.7x

Dividend Yield (Forecast)

2.98%

ROE

5.0%

EV/EBITDA

6.8x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	9,563	11,359	12,406	12,766	12,688
Cost of Sales	4,686	6,047	6,408	6,793	6,594
Gross Profit	4,876	5,311	5,997	5,973	6,094
SG&A Expenses	4,577	4,742	5,281	5,169	5,402
Operating Income	299	569	716	804	692
Non-operating Income	49	57	102	77	105
Non-operating Expenses	8	3	2	10	24
Ordinary Income	340	623	815	870	773
Extraordinary Income	44	—	5	—	—
Extraordinary Losses	—	—	—	97	—
Pre-tax Income	385	623	820	772	773
Income Taxes	101	131	123	225	144
Net Income	283	491	697	547	628
EBITDA	884	1,196	1,292	1,382	1,288
Gross Margin	51.0%	46.8%	48.3%	46.8%	48.0%
Operating Margin	3.1%	5.0%	5.8%	6.3%	5.5%
ROA	2.0%	3.0%	4.1%	3.1%	3.4%
ROE	2.7%	4.5%	5.9%	4.5%	5.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
コンシューマー事業	4,724	-100	-2.1%
ソリューション事業	7,956	799	10.0%
その他	7	-7	-100.0%